Mr. Saunders believes the eye health market will grow 20 percent over the next two years. Currently the company’s portfolio is 40 percent pharmaceutical, 40 percent vision and 20 percent surgical. Next year, the company expects that to change to 42 percent for pharmaceutical, 38 percent for vision care and 20 percent for surgical.
Related Articles on Ophthalmology:
Eyelid Surgery Provides Significant Improvement in Vision
VICTUS Femtosecond Laser Platform Gets CE Mark Approval
TearLab Gets FDA Approval for Wider Use of Eye Test
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
